Skip To Main Content

Transplantační medicína

Nejnovější trendy

Prozkoumejte nejčtenější články a videa na Campus Sanofi

Seřadit

LIBERTY AD SOLO-CONTINUE (18+ years)

LIBERTY AD SOLO-CONTINUE was a randomized, double-blind, phase 3 clinical trial at 185 sites in North America, Europe, Asia, and Japan.

LIBERTY AD HAFT (12+)

LIBERTY AD HAFT was a randomized phase 3 trial in adults and adolescents with moderate-to-severe hand and foot atopic dermatitis inadequately controlled with topicals.

DUPIXENT delivers a high standard of efficacy in adults

Efficacy is shown through real-world evidence, skin bacterial microbiome, trans-epidermal water loss (TEWL), and nonatopic comorbidities.

Infant and young child data

Significant improvement in Worst Scratch and Itch NRS score, Skin Clearance, and Children’s Dermatology Life Quality Index (CDLQI).

DUPIXENT delivers a high standard of efficacy in children

Efficacy is shown through 3 years of disease control, impact on growth curve, and improvement in mental health.​

PCSK9 inhibitor nebo inklisiran - Úvahy v klinické praxi

CRSwNP - Sense of smell avatar

Recent Insights from the BioDay Registry

Recent Insights from the BioDay Registry

Recent Insights from the BioDay Registry

Vakalarla Toujeo'ya Geçiş - Şengül Aydın Yoldemir ile Detemir'den Touejo'ya geçiş

“Vakalarla Toujeo’ya Geçiş”, diyabet tedavisinde Toujeo’ya geçişi gerçek hasta vakaları ve hekim deneyimleriyle ele alan, pratik klinik içgörüler sunan bir video serisidir.

Vakalarla Toujeo'ya Geçiş - Şengül Aydın Yoldemir ile Detemir + Aspart'tan Toujeo'ya geçiş

“Vakalarla Toujeo’ya Geçiş”, diyabet tedavisinde Toujeo’ya geçişi gerçek hasta vakaları ve hekim deneyimleriyle ele alan, pratik klinik içgörüler sunan bir video serisidir.